Epidemiology of vasculitides: Differences between Japan, Europe and North America

Clinical and Experimental Nephrology

Volumn 17, Issue 5, 2013, Pages 611-614

  Kobayashi, Shigeto ^a   Fujimoto, Shouichi ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

09:01; Giant cell arteritis; Granulomatosis with polyangiitis; HLA DRB1; Microscopic polyangiitis; Rapidly progressive glomerulonephritis; Takayasu's arteritis

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AGE DISTRIBUTION; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; ETHNIC DIFFERENCE; EUROPE; GENETIC ANALYSIS; GENOTYPE; GIANT CELL ARTERITIS; HAPLOTYPE; HUMAN; JAPAN; NORTH AMERICA; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; REVIEW; T LYMPHOCYTE;

CONTINENTAL POPULATION GROUPS; EUROPE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; JAPAN; NORTH AMERICA; PHENOTYPE; RESIDENCE CHARACTERISTICS; RISK FACTORS; VASCULITIS;

EID: 84887243875     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0813-9     Document Type: Review

References (23)

1. Kobayashi S, Fujimoto S, Takahashi K, Suzuki K. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan. Kidney Blood Press Res. 2010;33:442-55.
2. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43:414-9.
3. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG. Geoepidemilogy of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis. 2001;60:170-2.
4. Numano F. Differences in clinical presentation and outcome in different countries for Takayasu's arteritis. Curr Opin Rheumatol. 1997;9:12-5.
5. Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, Yutani C, Nakayama T, Tamakoshi A, Kawamura T, Ohno Y, Inaba Y, Hashimoto H. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum. 2003;49:594-8.
6. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-99.
7. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol. 1992;19:277-80.
8. Kobayashi S, Yano T, Inaba Y, Hashimoto H, Matsumoto Y, Tamakoshi A, Kawamura T, Ohno Y. Ocular involvement of Japanese patients with giant cell arteritis from the first nation-wide survey. Arthritis Rheum. 2003;49:867-8.
9. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with wegener's granulomatosis with anti-myeloperoxidase. Kidney Int. 2005;68:2225-9.
10. Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S, Harabuchi Y, Kobayashi S, Suzuki K, Hashimoto H, Watts RA, Scott DGI, Jayne DRW, et al. Renal vasculitis in Japan and the UK-are there differences in epidemiology and clinical phenotype? Nephrolol Dial Transplant. 2008;23:3928-31.
11. Kishibe K, Ueda S, Ishi H, Takahara K, Kunibe I, Katada A, Hayashi T, Harabuchi Y. Clinical manifestation of patients with Wegener's granulomatosis in Asahikawa, Hokkaido. Oto-Rhino Laringol. 2009;112:396 (in Japanese).
12. Tsuzuki K, Fukazawa K, Takebayashi H, Hashimoto K, Sakagami M. Difficulty of diagnosing Wegener's granulomatosis in the head and neck region. Auris Nasus Larynx. 2009;36(1):64-70.
13. Ishida Y, Katada A, Kishibe K, Imada M, Hayashi T, Nonaka S, et al. Wegener's granulomatosis with otolaryngological symptoms. Practica Oto-Rhino-Laryngologica. 2004;97:997-1005.
14. Takagi D, Nakamaru Y, Maguchi S, Furuta Y, Fukuda S. Otologic manifestations of Wegener's granulomatosis. Laryngoscope. 2002;112:1684-90.
15. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nölle B, Heller M, Gross WL. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000;43:1021-32.
16. Hoffman GS, Kerr GS, Leavbitt RY, Hallahan CW, Lebovics RS, Travis W, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-98.
17. Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, Tokunaga K, Hashimoto H. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB10901 with microscopic polyangiitis. J Rheumatol. 2003;30:1534-40.
18. Tsuchiya N, Kobayashi S, Hashimoto H, Ozaki S, Tokunaga K. Association of HLA-DRB10901-DQB10303 haplotype with microscopic polyangiitis in Japanese. Genes Immun. 2006;7:81-4.
19. Nakamaru Y, Maguchi S, Takizawa M, Fukuda S, Inuyama Y. The association between human leukocyte antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis in a Japanese population. Rhinology. 1996;34:163-5.
20. Seta N, Kobayashi S, Hashimoto H, Kuwana M. Characterization of autoreactive T-cell clones to myeloperoxidase in patients with microscopic polyangiitis and healthy individuals. Clin Exp Rheumatol. 2009;27:826-9.
21. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, Hashimoto H, Nunoi H. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford). 2011;50:1916-20.
22. Tougan T, Onda H, Okuzaki D, Kobayashi S, Hashimoto H, Nojima H. Focused microarray analysis of peripheral mononuclear blood cells from Churg-Strauss syndrome patients. DNA Res. 2008;15:103-14.
23. Kobayashi S, Ito A, Okuzaki D, Onda H, Yabuta N, Nagamori I, Suzuki K, Hashimoto H, Nojima H. Expression profiling of PBMC-based diagnostic gene markers isolated from vasculitis patients. DNA Res. 2008;15:253-65.